Loading organizations...
Loading organizations...
Metagen Therapeutics has raised $35.5M across 3 funding rounds.
Metagen Therapeutics has raised $35.5M in total across 3 funding rounds.
Metagen Therapeutics has raised $35.5M in total across 3 funding rounds.
Metagen Therapeutics's investors include Yuto Sasaki, Canon Marketing Japan, MEDIPAL HOLDINGS CORPORATION, Sayuri Okamoto, Arcus South East Asia, Dentsu Ventures, Jafco Ventures, Japan Bank for International Cooperation, Keio Innovation Initiative, Mizuho Capital, SMBC Venture Capital, SPARX Asset Management.
Metagen Therapeutics has raised $35.5M across 3 funding rounds. Most recently, it raised $7.6M metagen-therapeutics in February 2026.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Feb 26, 2026 | $7.6M metagen-therapeutics | Yuto Sasaki, Canon Marketing Japan, MEDIPAL HOLDINGS CORPORATION, Sayuri Okamoto | |
| Sep 10, 2025 | $15.8M Series B | Arcus South East Asia, Dentsu Ventures, Jafco Ventures, Japan Bank for International Cooperation, Keio Innovation Initiative, Mizuho Capital, SMBC Venture Capital, SPARX Asset Management | |
| Jun 15, 2023 | $12.1M Series A | Jafco Ventures, JIC Venture Growth Investments, Keio Innovation Initiative, Keisuke Omori, Sayuri Okamoto, SMBC Venture Capital, Mitsuhiro Ito |